Ignite Creation Date:
2024-05-06 @ 7:32 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02554279
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2015-09-09
Brief Title:
MENOPUR in a Gonadotropin-Releasing Hormone GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Study Overview
Official Title:
A Randomized Assessor-blind Trial Comparing MENOPUR Menotropins for Injection and Recombinant FSH Follicle Stimulating Hormone in a GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population
Status:
COMPLETED
Status Verified Date:
2019-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MEGASET HR
Brief Summary:
The purpose of this trial is to demonstrate non-inferiority of MENOPUR versus recombinant Follicle Stimulating Hormone rFSH Gonal-f with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation COS following GnRH treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None